DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20212934

Therapeutic enhancement of antibiotics using probiotics: a review

Bharat Kwatra, Rajani Raghavendra, Rutuja Sandip Patre, Dhvani H. Kuntawala

Abstract


This article was an examination of the therapeutic enhancement of antibiotics using probiotics. The scientific development and subsequent enhancement of antibiotics continued to influence the researchers all over the globe today. This article examined the research done and published by researchers and scientists. Consideration of current trends and data in scientific queries and demonstrated further aspects of probiotics and antibiotics. Additionally, this article explored options for therapeutic enhancement of ofloxacin, amoxicillin and cefuroxime.


Keywords


Antibiotics, Probiotics, Ofloxacin, Amoxicillin, Cefuroxime, Review, Therapeutic enhancements

Full Text:

PDF

References


Sharma JB, Chanana C, Kumar S, Roy K, Malhotra N. Comparison of ofloxacin & ornidazole with probiotic versus doxycycline & metronidazole for the outpatient treatment of pelvic inflammatory disease. J K Sci. 2007;9(2).

Ashraf R, Shah NP. Antibiotic resistance of probiotic organisms and safety of probiotic dairy products. Int Food Res J. 2011;18(3):837-53.

Monk JP, Campoli-Richards DM. Ofloxacin a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1987;33(4):346-91.

Tripathy S, Adhya A. Ofloxacin induced leucopenia in complicated falciparum malaria: a case report. Cases J. 2009;2:7097.

Hayakawa I, Atarashi S, Yokohama S, Imamura M, Sakano K, Furukawa M. Synthesis and antibacterial activities of optically active ofloxacin. Antimicrob Agents Chemother. 1986;29(1):163-4.

Ishibashi N, Yamazaki S. Preobiotics and safety. Am J Clin Nutr. 2001;73(2):465-70.

Monk JP, Campoli-Richards DM. Ofloxacin a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1987;33(4):346-91.

Williams NT. No Title. Am J Heal Pharm. 2010;Oxford Uni:Probiotics.

Boyanova L, Mitov I. Coadministration of probiotics with antibiotics: why, when and for how long? Expert Rev Anti Infect Ther. 2012;10(4):407-9.

Tolone S, Pellino V, Vitaliti G, Lanzafame A, Tolone C. Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone. Ital J Pediatr. 2012;38(1):63.

Stillits HV, Andrade A, Matos C, Lopes J, Pires T, Joaquim JJ. Preventing antibiotic-associated diarrhea. J Spec Pediatr Nurs. 2010;15(2):160-2.

Li B, Zheng J, Zhang X, Hong S. Probiotic Lactobacillus shirota improves efficacy of amoxicillin sulbactam against childhood fast breathing pneumonia in a randomized placebo controlled double blind clinical study. J Clin Biochem Nutr. 2018;63(3):233-7.

Influence of probiotic mix.

Gong Y, Li Y, Sun Q. Probiotics improve efficacy and tolerability of triple therapy to eradicate Helicobacter pylori: a meta-analysis of randomized controlled trials Int J Clin Exp Med. 2015;8(4):6530-43.

Kabbani TA, Pallav K, Dowd SE, Villafuerte-Galvez J, Vanga RR, Castillo NE, et al. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers. Gut Microbes. 2017;8(1):17-32.

Shafaghi A, Pourkazemi A, Khosravani M, Asl SF, Maafi AA, Roshan ZA, et al. The effect of probiotic plus prebiotic supplementation on the tolerance and efficacy of Helicobacter pylori eradication quadruple therapy: a randomized prospective double blind controlled trial. Middle East J Dig Dis. 2016;8(3):179-88.

Ladirat SE, Schoterman MHC, Rahaoui H, Mars M, Schuren FHJ, Gruppen H, et al. Exploring the effects of galacto-oligosaccharides on the gut microbiota of healthy adults receiving amoxicillin treatment. Br J Nutr. 2014;112(4):536-46.

Du YQ, Su T, Fan JG, Lu YX, Zheng P, Li XH, et al. Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection. World J Gastroenterol. 2012;18(43):6302-7.

Govender M, Choonara YE, Vuuren VS, Kumar P, Du TLC, Pillay V. Design and evaluation of an oral multiparticulate system for dual delivery of amoxicillin and Lactobacillus acidophilus. Future Microbiol. 2016;11(9):1133-45.

Dobreva L, Koprinarova N, Bratchkova A, Danva S. Antibiotic susceptibility of lactobacillus plantarum strains, isolated from Katak. Bulg J Vet Med. 2020.

Kong XX, Jiang JL, Qiao B, Liu H, Cheng JS, Yuan YJ. The biodegradation of cefuroxime, cefotaxime and cefpirome by the synthetic consortium with probiotic Bacillus clausii and investigation of their potential biodegradation pathways. Sci Total Environ. 2019;651:271-80.

Kamal SS, Hyldig N, Krych Ł, Greisen G, Krogfelt KA, Zachariassen G, et al. Impact of early exposure to cefuroxime on the composition of the gut microbiota in infants following cesarean delivery. J Pediatr. 2019;210:105.

Nurgaziyev M, Aitenov Y, Khassenbekova Z, Akpanova S, Rysbekov K, Kozhakhmetov S, et al. Effect of Mare’s milk prebiotic supplementation on the gut microbiome and the immune system following antibiotic therapy. Biodiversitas. 2020;21(11).